Company Filing History:
1 out of 6 
1 out of 3 Years Active: 2017-2018
Title: Innovations by Inventor Jose Costa
Introduction
Jose Costa is an accomplished inventor based in Guilford, CT (US). He has made significant contributions to the field of medical technology, particularly in the area of prostate cancer risk assessment. With a total of two patents to his name, Costa's work focuses on predictive models that utilize clinical and molecular information to improve patient outcomes.
Latest Patents
Costa's latest patents include a "Method and system for determining the risk of occurrence of prostate cancer" and a "System for evaluating a pathological stage of prostate cancer." The first patent describes a predictive model that assesses the risk of prostate cancer progression based on various clinical features, including preoperative PSA levels and Gleason scores. The model incorporates morphometric measurements derived from image analysis of tissue samples, enhancing the accuracy of risk predictions. The second patent outlines a system that predicts whether a patient is likely to have a favorable pathological stage of prostate cancer, utilizing similar clinical and morphometric data to inform its assessments.
Career Highlights
Throughout his career, Jose Costa has worked with notable organizations, including the Champalimaud Foundation. His experience in these institutions has allowed him to collaborate on groundbreaking research aimed at improving cancer diagnostics and treatment strategies.
Collaborations
Costa has collaborated with professionals such as Michael Donovan and Faisal Khan, contributing to a multidisciplinary approach in his research endeavors.
Conclusion
Jose Costa's innovative work in the field of prostate cancer risk assessment exemplifies the impact of technology on healthcare. His patents reflect a commitment to advancing medical knowledge and improving patient care through predictive modeling.